Actinium Pharmaceuticals Inc (NYSE MKT LLC:ATNM)

3.94
Delayed Data
As of May 29
 +0.41 / +11.61%
Today’s Change
2.31
Today|||52-Week Range
13.70
-33.11%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close3.53
Today’s open3.55
Day’s range3.46 - 4.10
Volume2,578,848
Average volume (3 months)695,556
Market cap$126.5M
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)-91.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd0.000.00%
SMMTSummit Therapeutics ...-0.03-0.29%
CLCDCoLucid Pharmaceutic...+0.20+2.36%
LPCNLipocine Inc-0.01-0.14%
Data as of 3:59pm ET, 05/29/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$0.00
Annual profit (last year)-$24.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Kaushik J. Dave
Chief Operating &
Medical Officer
Dragan Cicic
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers